COLINZ LABORATORIES LTD. Share Price

₹ 69.25

+0.00 (0.00%)
1D
Last updated 02 Nov, 2026, 09:08 IST
BSE: 531210
|
Pharmaceuticals

COLINZ LABORATORIES LTD. Share Price Today

As of 2 Nov 2026, COLINZ LABORATORIES LTD. share price is ₹69.25. The stock opened at ₹69.25, compared to its previous close of ₹69.25. During today's trading session, COLINZ LABORATORIES LTD. share price moved in the range of ₹69.25 to ₹69.25, with an average price of ₹69.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹36.11 and a high of ₹87.91.

Share price over the last 1 day rose from 70.00 to 70.99, ranging between 67.50 and 72.39.

₹69.25
0.00% up today
₹69.25
1D LOW
1D HIGH

COLINZ LABORATORIES LTD. Stock Insights

Stock Performance
OutperformingBeat Nifty by 47.79 % in last 6 month
COLINZ LABORATORIES LTD. stock performance
Open₹69.25
High₹69.25
Low₹69.25
Prev. close₹69.25
COLINZ LABORATORIES LTD. trading activity
Volume1
Average traded price₹69.25
Last traded time09:08:15 02 Nov
Last traded quantity1

Circuit
L
H
₹62.33
₹76.17
52-week
L
H
₹36.11
₹87.91
Mkt Cap Cr
17.44

P/E
6.24

P/B
1.74

ROA
18.86%
ROE
3.9%

ROCE
5.4%

Quick Ratio
3.65

EV/EBITDA
1.83

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Colinz Labs has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Colinz Labs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

COLINZ LABORATORIES LTD. Company Background

ISIN
INE923C01011
Sector Market Cap
₹ 17.44 Cr

Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.

COLINZ LABORATORIES LTD. Financial Highlights

  • Revenue: COLINZ LABORATORIES LTD. reported revenue of ₹6.62 crore in FY26 vs ₹6.83 crore in FY25. It showed a decrease of 3.07% on a yearly basis.
  • Operating Profit: COLINZ LABORATORIES LTD. reported an operating profit of ₹0.69 crore in FY26 vs ₹0.62 crore in FY25. It showed an increase of 11.29% on a year-on-year basis.
  • Net Profit: COLINZ LABORATORIES LTD. reported a net profit of ₹0.51 crore in FY26 vs ₹0.50 crore in FY25. It showed an increase of 2.00% on a yearly basis.

COLINZ LABORATORIES LTD. Quarterly Result Highlights

  • COLINZ LABORATORIES LTD. reported revenue of ₹1.69 crore in Sep 2026, compared with ₹1.36 crore in Jun 2026, representing an increase of 24.26% on a quarter-on-quarter (QoQ) basis.
  • COLINZ LABORATORIES LTD. reported an operating profit of ₹0.19 crore in Sep 2026, compared with ₹2.90 crore in Jun 2026, representing a decrease of 93.45% on a quarter-on-quarter (QoQ) basis.
  • COLINZ LABORATORIES LTD. reported a profit of ₹0.13 crore in Sep 2026, compared with ₹2.40 crore in Jun 2026, reflecting a decrease of 94.58% on a QoQ basis.
  • The earnings per share (EPS) of COLINZ LABORATORIES LTD. stood at ₹2.04 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
50.60%
FII
0.00%
Other DII
0.00%
Retail and other
49.40%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

COLINZ LABORATORIES LTD. Investment Returns

1 day
-1.07%

1 week
+2.59%

1 month
-9.70%

1 year
+57.46%

3 years
+78.16%

5 years
+246.25%

COLINZ LABORATORIES LTD. Share Price History

COLINZ LABORATORIES LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹72.39 / ₹69.25
-1.07%
29 Oct 26
₹69.90 / ₹70.00
+1.45%
27 Oct 26
₹59.00 / ₹69.00
+9.45%
26 Oct 26
₹67.50 / ₹63.04
-6.61%
Show more

COLINZ LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6.14₹6.53₹7.03₹7.15
Other Income₹0.48₹0.30₹0.28₹0.17
Total Revenue₹6.62₹6.83₹7.30₹7.33
Total Expenses₹5.93₹6.21₹6.65₹6.73
Profit Before Tax₹0.69₹0.62₹0.65₹0.60
Tax₹0.17₹0.12₹0.16₹0.14
Profit After Tax₹0.51₹0.50₹0.49₹0.46
EPS - Basic₹2.04₹1.97₹1.93₹1.82
EPS - Diluted₹2.04₹1.97₹1.93₹1.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.69₹0.62₹0.65₹0.60
Income before WC changes₹0.41₹0.50₹0.54₹0.63
Change in Assets₹1.92-₹1.73₹0.37₹0.06
Change in Liabilities₹0.40-₹0.02₹0.30-₹0.14
Change in WC₹2.32-₹1.75₹0.67-₹0.07
Cash flow from Operations₹2.54-₹1.45₹1.03₹0.40
Cash flow from Investing₹0.01-₹0.23₹0.01₹0.01
Cash flow from Financing₹0.43₹0.24₹0.23₹0.11
Total Cash Flow₹2.98-₹1.45₹1.27₹0.52
Cash (Start of the year)₹5.55₹7.00₹5.73₹5.21
Cash (End of the year)₹8.53₹5.55₹7.00₹5.73

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2.70₹2.80₹2.62₹2.40
Current Assets₹10.08₹9.02₹8.74₹7.84
Total Assets₹12.78₹11.82₹11.36₹10.23
Current Liabilities₹2.57₹2.16₹2.18₹1.89
Net Current Asset₹7.51₹6.85₹6.55₹5.95
Non-Current Liabilities₹0.17₹0.18₹0.23₹0.21
Equity Capital₹10.04₹9.47₹8.95₹8.14
Total Equity & Liabilities₹12.78₹11.82₹11.36₹10.23
* All values are in INR Crore
COLINZ LABORATORIES LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
269.2500
0000
0000
0000
0000
Total bid quantity2
Total ask quantity0
COLINZ LABORATORIES LTD. technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
47.79
Neutral

ATR (14)
4.79
Neutral

STOCH(9,6)
75.93
Neutral

STOCH RSI (14)
91
Bearish

ADX(9)
62.26
Bearish

UO(9)
62.04
Neutral

ROC(12)
-1.1
Bearish

WillR(14)
-35.9
Neutral
Period
Simple value
Exponential vaue

5D
67.76
68.48

10D
68.09
68.57

20D
70.01
69.69

50D
72.41
71.48

100D
73.16
69.6
Volume trend — traded volume by day
30 Oct0L
29 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

COLINZ LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

COLINZ LABORATORIES LTD. Returns Calculator

COLINZ LABORATORIES LTD. Share Price FAQs












Please be aware that COLINZ LABORATORIES LTD. stock prices are subject to continuous fluctuations due to various factors.